Home > Publications > Medical Specialty > Internal Medicine > Haematology > Haematology > Haematology Research Review, Issue 127
Haematology Research Review, Issue 127

Haematology Research Review, Issue 127

In this issue:

Imetelstat for relapsed/erythropoiesis-stimulating agent refractory lower-risk MDS
Extended letermovir prophylaxis in SCT recipients at CMV infection risk
Predicting cytopenias, progression and survival in CCUS
CV toxicities associated with BTEs
First-line ibrutinib and venetoclax for treatment-naïve Waldenströms
CD24 fusion protein for GVHD prevention
Maintenance venetoclax/azacitidine after RIC allogeneic SCT in high-risk MDS/AML
Fedratinib for myelofibrosis after ruxolitinib failure
CEAC vs. BEAM conditioning for autologous SCT in DLBCL
Avatrombopag: early versus chronic ITP

You need to be logged in to access this content.

Jeff-Szer

Expert contributor

Professor Jeff Szer

Professor Jeff Szer AM (@marrow), is a member of the Clinical Haematology team at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He is also Director of the Western and Central Melbourne Integrated Cancer Service and outgoing President of the World Marrow Donor Association. He established the first adult bone marrow transplant centre in […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.